|
gptkbp:instanceOf
|
gptkb:investor
|
|
gptkbp:assetsUnderManagement
|
over $2 billion
|
|
gptkbp:focusesOn
|
gptkb:biotechnology
healthcare
life sciences
medical device
|
|
gptkbp:foundedIn
|
1996
|
|
gptkbp:founder
|
gptkb:Dr._Garrett_Gruener
gptkb:Dr._Jean_Deleage
gptkb:Dr._Marino_Polestra
gptkb:Guy_Paul_Nohra
|
|
gptkbp:headquartersLocation
|
gptkb:San_Francisco,_California,_United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Alta Partners
|
|
gptkbp:industry
|
venture capital
|
|
gptkbp:notableInvestment
|
gptkb:Zynga
gptkb:Agensys
gptkb:Allakos
gptkb:Calithera_Biosciences
gptkb:DeCode_Genetics
gptkb:Esperion_Therapeutics
gptkb:IntraLase
gptkb:Taligen_Therapeutics
gptkb:Tyra_Biosciences
gptkb:Aerie_Pharmaceuticals
gptkb:MyoKardia
|
|
gptkbp:parentCompany
|
gptkb:Alta_Group
|
|
gptkbp:regionServed
|
gptkb:United_States
global
|
|
gptkbp:website
|
https://www.altapartners.com/
|
|
gptkbp:bfsParent
|
gptkb:Garrett_Gruener
|
|
gptkbp:bfsLayer
|
6
|